Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
Remaining Time -0:00
1x
- 2x
- 1.75x
- 1.5x
- 1.25x
- 1x, selected
- 0.75x
- 0.5x
- 0.25x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
×
How would you rate this video
Thank you !
Thank you for your feedback! your rating has been recorded.
Cardiology
Lipitension - Interplay between Hypertension and Dyslipidaemia
Calcium antagonists have become the gold standard of antihypertensive efficacy. amlodipine is most often considered. This is due to its being more powerful in lowering BP than other dihydropyridine calcium antagonists
Calcium antagonists have become the gold standard of antihypertensive efficacy. Among various dihydropyridine calcium antagonists, amlodipine is most often considered. This is due to its being more powerful in lowering BP than other dihydropyridine calcium antagonists, and also more due to its extensive use by practicing physicians all over the world. CCBs are widely used for the treatment of hypertension and have effectiveness BP, major CV events, and mortality outcomes. Most RCTs demonstrating the benefits of CCBs on outcomes have used dihydropyridines (especially amlodipine).
Published 11 Dec 2020
Related Videos
Related Videos
Fungal infection and its...
03 Nov
Swedeheart Registry Video
18 Oct
Oasis-5 Trial
18 Oct
Role of Fondaparinux in...
02 Nov
Dr.Shamir Mehta on Oasis...
02 Nov
OASIS 8- Futura Trial...
02 Nov
SWEDEHEART Registry by Dr...
02 Nov
Close
Videos Speakers
Related Webinars
-
button
-
-
-
-
Heart FailureHeart Failure
HF Peer Exchange Forum
3 Speakers
There are 3 speakers in this webinar
03 Dec 2024
Webinar Speakers
Related Webinars
No result found. Choose another option for better results.
Webinar Speakers
Below fields are needed for webinar purpose.